X

Our publications

This informative section reflects the scientific influence that has our clinic. Indeed, for more than 10 years, the activities of the clinique ovo conducted by our team of doctors and researchers recognized is confirmed by numerous books and informational documents, presentations, publications of research data in several fields, including the fertility and prenatal particular.

  • Académie

  • Demande d’information (Accueil)

    Fields marked with an * are required
    Formulaire de questions

    *mentions obligatoires

  • Fields marked with an * are required
    Question form
    *mandatory information
  • Discover the ovo clinic

  • Contact us

    Contact us

    clinique ovo montreal

    All services offered 8000, boul. Décarie,
    Montreal Qc H4P 2S4
    ovo fertility office 100 & 200
    Monday to Friday 7:30am to 6:00pm
    Weekend on appointment
    fertilite@cliniqueovo.com
    ovo elle bureau 600
    Monday to Friday 8:00am to 4:00pm
    elle@cliniqueovo.com
    ovo cryo Monday to Wed. 8:00am to 5:00pm
    Thursday 8:00am to 6:00pm
    Friday 8:00am to 5:00pm
    Saturday 9:00am to 3:00pm
    Appointments :
    Monday to Friday 9:00am to 3:00pm
    Thursday 9:00am to 4:00pm
    Saturday 9:00am to 2:30pm
    cryo@cliniqueovo.com
    ovo biosurance office 600
    Monday to Friday 8:00am to 4:00pm
    biosurance@cliniqueovo.com
    ovo labo office 600
    Monday to Friday 8:00am to 4:00pm
    labo@cliniqueovo.com
    ovo prenatal office 600
    Monday to Friday 8:00am to 4:00pm
    prenatal@cliniqueovo.com
    ovo r&d office 600
    Monday to Friday 7:15am to 5:00pm
    r-d@cliniqueovo.com

    clinique ovo rive-sud

    3141, boul. Taschereau,
    Greenfield Park Qc J4V 2H2
    ovo fertility - certain services offered office 410
    Call to know our hours
    fertilite@cliniqueovo.com
    ovo prenatal - certain services offered office 420
    Monday to Friday 8:00am to 4:00pm
    prenatal@cliniqueovo.com
    ovo labo - certain services offered office 420
    Monday to Friday 8:00am to 4:00pm
    labo@cliniqueovo.com

    clinique ovo quebec

    ovo prenatal - certain services offered 2600 Boul. Laurier, suite 295,
    Quebec Qc G1V 4T3
    Monday to Friday 8:00am to 4:00pm prenatal@cliniqueovo.com



    clinique ovo rive-nord

    ovo prenatal - Prenatal screening 1000 Montée des Pionniers,
    Terrebonne QC J6V 1S8
    Monday to Thursday 9:00am to 3:00pm
    prenatal@cliniqueovo.com

    clinique Echo-medic

    Ovo prenatal - certain services
    Laval 1575, boul. de l'Avenir, suite 110,
    Laval Qc H7S 2N5
    t. 1.877.664.3246
    Monday to Thursday 7:30am to 4:30pm
    Friday 7:30am to 3:00pm
    Boisbriand 20865, chemin de la Côte Nord, suite 201
    Boisbriand Qc J7E 4H5
    t. 1.877.664.3246
    Monday to Thursday 8:00am to 4:00pm
    Friday 8:00am to 3:00pm
    Montreal and South-Shore: t. 514.798.2000
    Quebec: t. 418.425.0128
    f. 514.798.2001
  • Make an appointment

  • October 2011 : ASRM, 67th annual meeting, Orlando Florida

    Surgically retrieved sperm versus ejaculated sperm in modified natural in vitro fertilization-intracytoplasmic sperm injection (MNIVF-ICSI) cycles.

  • October 2011 : ASRM, 67th annual meeting, Orlando Florida

    Cumulative clinical pregnancy rates privileging elective single embryo transfer: a mathematical model from the Quebec (Canada) publicly-funded in vitro fertilisation (IVF) Program.

  • October 2011 : ASRM, 67th annual meeting, Orlando Florida

    Prolonged Course Of Luteal Estradiol In Preparation To In Vitro Fertilization Cycles: An Analysis Of Microdose Flare-Up And Antagonist Stimulation Protocols.

  • September 2011 : CFAS, 57th annual meeting, Toronto

    Renewal of culture media on day 4 of human IVF embryo development results in a higher blastulation rate when compared to supplementation of the media.

  • September 2011 : CFAS, 57th annual meeting, Toronto

    Prolonged course of luteal estradiol in preparation for IVF cylces reduces pregnancy rates.

  • September 2011 : CFAS, 57th annual meeting, Toronto

    Fertility Clinic Web site in Canada: how are we doing?

  • April 2011 : Journée de la recherche, Université de Montreal – département d’obstétrique-gynécologie – Montréal

    La qualité de l’implantation en fécondation in vitro: comparaison entre le cycle naturel et le cycle stimulé

  • 2011 : Human reproduction 26 (suppl 1): i-113

    F. Bissonnette, S. Phillips, H. Holzer, N. Mahutte, P. St-Michel, J. Gunby, I.J. Kadoch. Funding is the most powerful tool against multiple pregnancies in ART.

  • 2011 : Human reproduction 26 (suppl 1): p-561

    M.P. Velez, G. Abad, J.M. Robert, F. Bissonnette, I.J. Kadoch. Quality assessment of fertility clinic websites in Canada: a comprehensive approach.

  • 2011 : Human reproduction 26 (suppl 1): p-563

    P. Monnier, O. Sheehy, W. Fraser, F. Bissonnette, S.l. Tan, J. Trasler, S. Chaabane, A. Berard. Who uses ovarian stimulation along among users of medically assisted reproduction with liveborns? Results from the TWINPREG study.

  • October 2010 : CFAS, 56th Annual Meeting, Vancouver

    Anti-sperm antibody levels are not related to fertilization or pregnancy rates at IVF and ICSI.

  • October 2010 : CFAS, 56th Annual Meeting, Vancouver

    Influence of seminal catalase activity on IVF pregnancy.

  • June 2010 : ESHRE annual meeting

    A novel and unifying approach to predict endometrial receptivity: significance of hormonal ratios to oocyte number in in-vitro fertilisation

  • June 2010 : ESHRE annual meeting

    An algorithm combining ultrasound monitoring and urinary luteinizing hormone testing: a novel approach for timing intrauterine insemination

  • November 2009 : CFAS, 55 th annual meeting – Montreal Qc

    The presence of anti-sperm antibodies is not associated with sperm DNA damage : prospective study of infertile men

  • June 2009 : ESHRE

    Lédée-Bataille N, Olivennes F, Kadoch IJ, Dubanchet S, Frydman N, Chaouat G, Frydman R. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer.

  • September 2007 : CFAS 2007-09_Epididymal sperm quality

    Epididymal sperm quality may influence ICSI outcome: role of TESE in men with obstructive azoospermia.

  • September 2007 : CFAS 2007-09_Assessment of sperm DNA integrity

    Assessment of sperm DNA integrity and strict morphology reveals a novel relationship between DNA damage and tail defects.

  • October 2006 : ASRM

    Increased Risk of Vasa Previa in Pregnancies Concieved After In Vitro Fertilisation: A Case Report and Literature Review.

  • October 2006 : ASRM

    Laparoscopic tubal anastamosis: The one-suture technique. Video Session,

  • October 2005 : ASRM

    Successful pregnancy by transmyometrial embryo transfer after IVF – S.M.A.R.T. protocol in a patient who underwent radical vaginal trachelectomy : case report.

  • October 2005 : ASRM

    Adding estrogen to progesterone in luteal phase support in In Vitro Fertilization – Embryo Transfer (IVF-ET) cycles produces pregnancies with higher quantitative beta human chorionic gonadotropins (ßhCG).

  • November 2004 : CFAS

    Ongoing pregnancy after ICSI of frozen-thawed percutaneous epididymal sperm aspiration (PESA) retrieved spermatozoa and in vitro fertilization in a natural cycle (nIVF).

  • October 2004 : ASRM , Fertility and Sterility (Vol. 82, Issue (Supplement 2), Page S319)

    Ledee-Bataille N, Dubanchet S, Kadoch IJ, Castello-Branco A, Frydman R, Chaouat G. Unstimulated IVF cycle: An alternative for patients with repeated unsuccessful IVF-ET and a high uterine NK cell count?

  • October 2004 : ASRM , Fertility and Sterility (Vol. 82, Issue (Supplement 2), Pages S318-S319)

    Ledee-Bataille N, Olivennes F, Kadoch IJ, Dubanchet S, Chaouat G, Frydman R.Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer.

  • October 2003 : ASRM , Fertility and Sterility (Sep;80(S3):2-3)

    Fanchin R, Branco AC, Kadoch IJ, Hosny G, Torrisi C, Frydman R. Premenstrual GnRH antagonist administration coordinates early antral follicle sizes and sets up bases for an innovative controlled ovarian hyperstimulation (COH) concept.

  • October 2003 : ASRM , Fertility and Sterility (Vol. 80, Issue (Supplement 3), Page 188)

    Kadoch IJ, Frydman N, Castelo Branco A, Lédée Bataille N, Fanchin R, Frydman R.IVF-ET using naturally-selected dominant follicle for poor prognosis patients : a hypothesis Fertility and Sterility

  • October 2002 : ASRM , Fertility and Sterility (Vol. 78, Issue (Supplement 1), Page S110)

    Lédée-Bataille N, Olivennes F, Frydman R, Taupin JL, Kadoch IJ, Chaouat G.Concentration of leukemia inhibitory foctor (LIF) in uterine flushing fluid is hightly predictive of embryo implantation

  • October 2002 : ASRM , Fertility and Sterility (Vol. 78, Issue (Supplement 1), Page S177)

    Olivennes F, Samama M, Kadoch IJ, Fanchin R, Righini C, Frydman R.Controlled ovarian stimulation using GnRH antagonist Cetrorelix single dose protocol: A comparative study with GnRH agonist treatment

  • July 2002 : ESHRE

    Kadoch IJ, Lédée-Bataille N, Samama M, Taupin JL, Dubanchet S, Chaouat G, Frydman R, Olivennes F.Assessment of leukaemia inhibitory factor levels by uterine flushing at the time of oocyte retrieval does not adversely affect IVF pregnancy rates.

  • July 2002 : ESHRE

    Samama M, Olivennes F, Fanchin R, Kadoch IJ, Righini C, Frydman R.One year treatment with GnRH antagonist single dose cetrorelix protocol in controlled ovarian hyperstimulation: a comparative study with GnRH agonist treatment.

  • July 2002 : ESHRE

    Fanchin R, Cunha Filho JS, Schönauer LM, Kadoch IJ, Cohen-Bacri P, Frydman R.Co-ordination of early antral follicles by luteal estradiol administration : basis for novel controlled ovarian hyperstimulation concepts.

  • October 2001 : ASRM , Fertility and Sterility (76: 3 (Supplement 1): S90)

    Fanchin R, Schönauer L, Cunha Filho J, Kadoch IJ, Cohen-Bacrie P, Frydman R. Lutal E2 administration reduces size and improves homogeneity of selectable follicles on cycle-day 3 : bases for novel controlled ovarian hyperstimulation (COH) concepts.